stella
beta
Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo — Stella
Recruiting
Back to NonSegmental Vitiligo trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Peking University Shenzhen Hospital, Shenzhen, Guangdong
View full record on ClinicalTrials.gov